Preferred Label : Hand-Foot syndrome;
MeSH definition : Chemotherapy-induced dermal side effects that are associated with the use of various
CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe
ulcerative dermatitis with debilitating pain involving typically palmoplantar and
intertriginous areas. These cutaneous manifestations are sometimes accompanied by
nail anomalies.;
MeSH synonym : Hand-Foot syndromes; syndrome, Hand-Foot; syndromes, Hand-Foot; Chemotherapy-Induced palmoplantar erythrodysesthesia; chemotherapy induced palmoplantar erythrodysesthesia; Chemotherapy-Induced palmoplantar erythrodysesthesias; palmoplantar erythrodysesthesia, Chemotherapy-Induced; palmoplantar erythrodysesthesias, Chemotherapy-Induced; Chemotherapy-Induced acral erythema; acral erythema, Chemotherapy-Induced; acral erythemas, Chemotherapy-Induced; chemotherapy induced acral erythema; Chemotherapy-Induced acral erythemas; hand foot syndrome;
MeSH annotation : do not confuse with HAND, FOOT AND MOUTH DISEASE;
Wikipedia link supervised : https://en.wikipedia.org/wiki/Hand-foot syndrome;
Origin ID : D060831;
UMLS CUI : C0549410;
Allowable qualifiers
Currated CISMeF NLP mapping
Indexing information
Ne pas confondre avec
Record concept(s)
See also
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Chemotherapy-induced dermal side effects that are associated with the use of various
CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe
ulcerative dermatitis with debilitating pain involving typically palmoplantar and
intertriginous areas. These cutaneous manifestations are sometimes accompanied by
nail anomalies.
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=2438
2014
false
true
false
France
scientific and technical information
uterus
Hand-Foot syndrome
---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/46/C8/resume.phtml?type=text.html
2009
false
France
French
journal article
phenylurea compounds
niacinamide
Tyrosine Kinase Inhibitors
benzenesulfonates
pyridines
Hand-Foot syndrome
antineoplastic agents
sorafenib
administration, oral
protein kinase inhibitors
sorafenib tosylate
receptors, vascular endothelial growth factor
kidney neoplasms
carcinoma, hepatocellular
receptors, platelet-derived growth factor
raf kinases
paresthesia
erythema
Sorafenib
---